Furthermore, the acid calcium‐independent phospholipase A2 (aiPLA2) inhibitor, MJ33, restores the GSH/GSSG balance and reverses the increase in ROS levels caused by D2HGDH knockdown, resulting in remission of epilepsy‐related behaviors. Here, D2HGDH is linked to epilepsy.